BRIEF-Intellipharmaceutics U.S.-listed shares up 93.1 percent premarket
November 19, 2013 at 07:39 AM EST
NEW YORK, Nov 19 (Reuters) - Intellipharmaceutics International Inc : * U.S.-listed shares up 93.1 percent to $3.65 in premarket; gets final FDA OK to commercially launch 15 and 30 mg generic Focalin XR
